HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Claire’s Caves, Recalls Makeup Products Following FDA’s Asbestos Finding

Executive Summary

The jewelry and cosmetics retailer announced March 11 that it is voluntarily recalling selected lots of three makeup products due to the “possible presence of asbestos fibers.” FDA issued a safety alert the previous week that has made Claire’s the latest poster child for cosmetics regulatory reform.

You may also be interested in...



SAI Lab Director ‘Elated’ By Federal Talc-Asbestos Testing Recs: ‘We Need To Be Aware That It’s There’

State-of-the-art testing approaches increasingly show that asbestos contamination of cosmetic talc is a concern worthy of the renewed attention it is receiving from federal agencies, says Scientific Analytical Institute’s research director Sean Fitzgerald.

FDA-Proposed Talc Testing Methods Likely Would Find Particles Of Concern; Then What?

The FDA is focused on driving adoption of more sensitive, standardized testing methods for assessing cosmetic talc purity, which it believes would yield more consistent results across labs. This would help to inform research into the health implications of trace levels of asbestos and other elongate mineral particles in talc; in the interim it could to be damaging to companies that supply or use that talc.

FDA Cosmetics Funding ‘Inadequate’ – Appropriators Propose $4m Increase

Proposing $4m bump in FY 2020 for Office of Cosmetics and Colors, House appropriators are "concerned that FDA’s current authority and resources to oversee cosmetics and personal care products are inadequate to properly ensure the safety of cosmetics products.”

Related Content

Topics

UsernamePublicRestriction

Register

RS148623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel